{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:44:48Z","timestamp":1793814288654,"version":"4.6.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Digest Science"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>The long-term safety and efficacy of allogeneic bone marrow-derived mesenchymal stromal cell [bmMSC] therapy in perianal Crohn\u2019s disease [CD] fistulas is unknown. We aimed to provide a 4-year clinical evaluation of allogeneic bmMSC treatment of perianal CD fistulas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A double-blind dose-finding study for local bmMSC therapy in 21 patients with refractory perianal fistulising Crohn\u2019s disease was performed at the Leiden University Medical Center in 2012\u20132014. All patients treated with bmMSCs [1 x 107 bmMSCs cohort 1, n = 5; 3 \u00d7 107 bmMSCs cohort 2, n = 5; 9 \u00d7 107 bmMSCs cohort 3, n = 5] were invited for a 4-year evaluation. Clinical events were registered, fistula closure was evaluated, and anti-human leukocyte antigen [HLA] antibodies were assessed. Patients were also asked to undergo a pelvic magnetic resonance imaging [MRI] and rectoscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen out of 15 patients [87%] treated with bmMSCs were available for long-term follow-up. Two non-MSC related malignancies were observed. No serious adverse events thought to be related to bmMSC therapy were found. In cohort 2 [n = 4], all fistulas were closed 4 years after bmMSC therapy. In cohort 1 [n = 4] 63%, and in cohort 3 [n = 5] 43%, of the fistulas were closed, respectively. In none of the patients anti-HLA antibodies could be detected 24 weeks and 4 years after therapy. Pelvic MRI showed significantly smaller fistula tracts after 4 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Allogeneic bmMSC therapy for CD-associated perianal fistulas is also in the long-term a safe therapy. In bmMSC-treated patients, fistulas with closure at Week 24 were still closed after 4 years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjz116","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T07:10:39Z","timestamp":1560409839000},"page":"64-70","source":"Crossref","is-referenced-by-count":118,"title":["Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn\u2019s Disease Perianal Fistulas"],"prefix":"10.1093","volume":"14","author":[{"given":"Marieke C","family":"Barnhoorn","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin N J M","family":"Wasser","sequence":"additional","affiliation":[{"name":"Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Roelofs","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P W Jeroen","family":"Maljaars","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Molendijk","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert A","family":"Bonsing","sequence":"additional","affiliation":[{"name":"Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth E M","family":"Oosten","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Dijkstra","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Janneke","family":"van der Woude","sequence":"additional","affiliation":[{"name":"Deparment of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave L","family":"Roelen","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap-Jan","family":"Zwaginga","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein W","family":"Verspaget","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem E","family":"Fibbe","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W","family":"Hommes","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen C M J","family":"Peeters","sequence":"additional","affiliation":[{"name":"Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea E","family":"van der Meulen-de Jong","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,14]]},"reference":[{"key":"2019122411073711200_CIT0001","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/gut.21.6.525","article-title":"Occurrence and outcome after primary treatment of anal fistulae in Crohn\u2019s disease","volume":"21","author":"Hellers","year":"1980","journal-title":"Gut"},{"key":"2019122411073711200_CIT0002","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","article-title":"The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota","volume":"122","author":"Schwartz","year":"2002","journal-title":"Gastroenterology"},{"key":"2019122411073711200_CIT0003","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/apt.13356","article-title":"Systematic review with meta-analysis: faecal diversion for management of perianal Crohn\u2019s disease","volume":"42","author":"Singh","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"2019122411073711200_CIT0004","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn\u2019s disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"2019122411073711200_CIT0005","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"2019122411073711200_CIT0006","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"2019122411073711200_CIT0007","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1097\/MIB.0000000000000148","article-title":"Disappointing durable remission rates in complex Crohn\u2019s disease fistula","volume":"20","author":"Molendijk","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2019122411073711200_CIT0008","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/nyas.12984","article-title":"Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization","volume":"1370","author":"Schepers","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"2019122411073711200_CIT0009","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease","volume":"149","author":"Molendijk","year":"2015","journal-title":"Gastroenterology"},{"key":"2019122411073711200_CIT0010","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells [Cx601] for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"key":"2019122411073711200_CIT0011","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/tan.12860","article-title":"How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?","volume":"88","author":"Kamburova","year":"2016","journal-title":"HLA"},{"key":"2019122411073711200_CIT0012","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ecco-jcc\/jjy220","article-title":"Lymphoproliferative disease in the rectum 4 years after local mesenchymal stromal cell therapy for refractory perianal Crohn\u2019s fistulas: a case report","volume":"13","author":"Barnhoorn","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2019122411073711200_CIT0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial","volume":"52","author":"Garcia-Olmo","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"2019122411073711200_CIT0014","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3727\/096368912X656045","article-title":"Autologous adipose tissue-derived stem cells for the treatment of Crohn\u2019s fistula: a phase I clinical study","volume":"22","author":"Cho","year":"2013","journal-title":"Cell Transplant"},{"key":"2019122411073711200_CIT0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","article-title":"Expanded allogeneic adipose-derived stem cells [eASCs] for the treatment of complex perianal fistula in Crohn\u2019s disease: results from a multicenter phase I\/IIa clinical trial","volume":"28","author":"de la Portilla","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"2019122411073711200_CIT0016","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garc\u00eda-Olmo","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"2019122411073711200_CIT0017","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2036.2003.01561.x","article-title":"The clinical course of fistulating Crohn\u2019s disease","volume":"17","author":"Bell","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"2019122411073711200_CIT0018","doi-asserted-by":"crossref","first-page":"e47559","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells [SafeCell]: a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"2019122411073711200_CIT0019","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.mayocp.2015.03.023","article-title":"Long-term follow-up of Crohn disease fistulas after local injections of bone marrow-derived mesenchymal stem cells","volume":"90","author":"Ciccocioppo","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"2019122411073711200_CIT0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0961203306075793","article-title":"Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus","volume":"16","author":"Sun","year":"2007","journal-title":"Lupus"},{"key":"2019122411073711200_CIT0021","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5966\/sctm.2014-0199","article-title":"Long-term results of adipose-derived stem cell therapy for the treatment of Crohn\u2019s fistula","volume":"4","author":"Cho","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"2019122411073711200_CIT0022","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy [Cx601] for complex perianal fistulas in patients with Crohn\u2019s disease","volume":"154","author":"Pan\u00e9s","year":"2018","journal-title":"Gastroenterology"},{"key":"2019122411073711200_CIT0023","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/codi.13223","article-title":"Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn\u2019s disease: a pilot clinical trial","volume":"18","author":"Park","year":"2016","journal-title":"Colorectal Dis"},{"key":"2019122411073711200_CIT0024","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/MEG.0000000000001208","article-title":"Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn\u2019s disease","volume":"30","author":"Molendijk","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjz116\/28996618\/jjz116.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/1\/64\/31613439\/jjz116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/1\/64\/31613439\/jjz116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T11:07:52Z","timestamp":1577185672000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/14\/1\/64\/5518414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,14]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,6,14]]},"published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz116","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,1]]},"published":{"date-parts":[[2019,6,14]]}}}